ABO Blood Group and the Risk and Prognosis of Lymphoma
Journal of Inflammation Research · 2023-02 · Volume 16 · 769-778
DOI: 10.2147/jir.s401818 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2023-02. Verfasst von Ling Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, People's Republic of China.
- Laboratory for Precision Medicine, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, People's Republic of China.
- Section for Statistical Analysis and Data Collection, Luoyang Branch, Bank of China, Luoyang, People's Republic of China.
ORCID-Profile: Qinan Yin
Zitieren
APA
Qin, L., Gao, D., Wang, Q., Zheng, X., Wang, J., Chen, X., Fu, D., Ma, H., Tan, J., & Yin, Q. (2023). ABO Blood Group and the Risk and Prognosis of Lymphoma. Journal of Inflammation Research, Volume 16, 769-778. https://doi.org/10.2147/jir.s401818
Vancouver
Qin L, Gao D, Wang Q, Zheng X, Wang J, Chen X, et al. ABO Blood Group and the Risk and Prognosis of Lymphoma. Journal of Inflammation Research. 2023;Volume 16:769-778. doi:10.2147/jir.s401818
BibTeX
@article{Qin2023,
author = {Qin, Ling and Gao, Dongli and Wang, Qian and Zheng, Xuewei and Wang, Jingjing and Chen, Xingang and Fu, Dongliao and Ma, Haodi and Tan, Junjia and Yin, Qinan},
title = {ABO Blood Group and the Risk and Prognosis of Lymphoma},
journal = {Journal of Inflammation Research},
year = {2023},
volume = {Volume 16},
pages = {769--778},
doi = {10.2147/jir.s401818}
}
EUVIMED